Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions

Details for Australian Patent Application No. 2010320870 (hide)

Owner NOVAGALI PHARMA SA

Inventors Garrigue, Jean-Sebastien; Lallemand, Frederic; Daull, Philippe; Baudouin, Christophe

Agent Griffith Hack

Pub. Number AU-A-2010320870

PCT Pub. Number WO2011/061298

Priority 10164376.5 28.05.10 EP; 61/262,664 19.11.09 US

Filing date 19 November 2010

Wipo publication date 26 May 2011

International Classifications

A61K 31/5575 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/061298 Priority application(s): WO2011/061298

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010320871-Thermal-chemical utilization of carbon-containing materials, in particular for the emission-free generation of energy

2010320869-Method for treating retinal conditions using an intraocular tamponade